Our Glycan-Based Drug Discovery services are designed to help pharmaceutical and biotechnology companies, as well as academic research institutions, leverage the power of glycomics for therapeutic development. This end-to-end service offering includes precision glycan analysis and high-throughput glycan profiling, supported by translational expertise in glycoprotein characterization and glycoengineering to help you advance your drug discovery and development efforts. Our Glycan-Based Drug Discovery services are suitable for a wide range of therapeutic areas including cancer, immunology, infectious diseases and more.
By addressing these challenges, we help our partners discover novel targets and optimize biotherapeutics.
Unmet therapeutic targets: Conventional approaches often overlook glycans, yet abnormal glycosylation is a hallmark of cancer, autoimmune diseases, and infectious disorders.
Complex glycan structures: Glycans are structurally diverse and difficult to analyze without specialized methods, creating barriers in drug R&D.
Batch-to-batch variability in biologics: Inconsistent glycosylation patterns can compromise the safety, efficacy, and regulatory approval of therapeutic proteins.
Lack of glycan-specific expertise: Many drug discovery pipelines lack in-house knowledge or technologies for high-resolution glycan characterization and engineering.
We provide high-resolution analytical solutions to fully characterize glycan structures in therapeutic proteins and biologics.
Our team identifies and validates glycan-related biomarkers and therapeutic targets for drug development.
We optimize glycosylation patterns in therapeutic proteins to improve safety, stability, and efficacy.
We offer custom-designed glycans and glycan analogs to support screening, mechanistic studies, and therapeutic development.
We accelerate the identification of glycan-based drug candidates using advanced screening platforms.
We ensure your biologics meet global regulatory standards with comprehensive glycan analysis.
Choosing our Glycan-Based Drug Discovery services means gaining a partner with both scientific depth and practical expertise.
Comprehensive Expertise: We integrate glycomics, proteomics, and drug development know-how to provide end-to-end solutions from discovery to regulatory support.
Cutting-Edge Technology: Our workflow is powered by state-of-the-art platforms including LC-MS, CE, HPLC, glycan microarrays, and advanced bioinformatics tools.
Customized Solutions: Every project is tailored to your therapeutic area, whether oncology, immunology, infectious disease, or biologics development.
Global R&D Acceleration: By shortening discovery timelines and reducing technical risks, we help pharmaceutical and biotech teams bring glycan-driven therapeutics to market faster.
Collaborative Partnership: Our experts work closely with your in-house team, ensuring knowledge transfer and long-term value beyond a single project.
We follow a streamlined, step-by-step workflow to ensure that every glycan-based drug discovery project is handled with precision, efficiency, and transparency.
We begin with a detailed discussion of your scientific goals, therapeutic focus, and regulatory requirements, followed by a customized project plan.
Using advanced platforms such as LC-MS, CE, and glycan microarrays, we analyze glycan structures, interactions, and signatures.
Our experts identify disease-relevant glycans, enzymes, or receptors and confirm their functional role in pathology.
We design glycan-optimized biologics, engineer homogeneous glycoforms, or synthesize custom glycans tailored to your project.
High-throughput screening and computational modeling are used to evaluate and refine lead compounds or therapeutic candidates.
We provide comprehensive analytical reports and validated datasets.
Final results are presented with clear recommendations, and ongoing consultation ensures smooth integration into your R&D pipeline.
Glycan-based drug discovery focuses on analyzing and leveraging glycosylation and glycan–protein interactions to identify novel therapeutic targets, optimize biologics, and accelerate drug development.
Glycans regulate key biological processes including immune recognition, pathogen entry, and cancer progression. Abnormal glycosylation patterns often serve as disease hallmarks, making glycans powerful targets for diagnostics and therapeutics.
We apply validated analytical workflows (LC-MS, CE, HPLC) under strict quality control standards and deliver reports.
Yes, we offer chemoenzymatic and enzymatic synthesis of defined glycans and analogs, tailored to screening, mechanistic studies, or therapeutic development.
Expand the impact of glycan-centric drug discovery with a team partner that can support your project with scientific, technological and regulatory strength. BOC Sciences provides glycan profiling, glycoengineering support, high throughput screening, and other tailored solutions to accelerate your pipeline and help you de-risk your program. In addition to glycan analytics and drug discovery services, we also offers off-the-shelf and custom-synthesized glycans ready to assist with N-linked glycans, O-linked glycans, sialylated glycans, fucosylated glycans, glycan analogs and other glycan-based needs, providing you with the necessary components to enable screening, assay development, and drug design.
Contact us today to discuss your project and explore how our Glycan-Based Drug Discovery services can help you move from complex glycan insights to breakthrough therapeutics.
